• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类系统性红斑狼疮性肾炎的数学框架:疾病动态与尿液生物标志物

Mathematical framework for human SLE Nephritis: disease dynamics and urine biomarkers.

作者信息

Budu-Grajdeanu Paula, Schugart Richard C, Friedman Avner, Birmingham Daniel J, Rovin Brad H

机构信息

Department of Mathematics, Ohio State University, Columbus OH 43210, USA.

出版信息

Theor Biol Med Model. 2010 May 17;7:14. doi: 10.1186/1742-4682-7-14.

DOI:10.1186/1742-4682-7-14
PMID:20478032
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2877652/
Abstract

BACKGROUND

Although the prognosis for Lupus Nephritis (LN) has dramatically improved with aggressive immunosuppressive therapies, these drugs carry significant side effects. To improve the effectiveness of these drugs, biomarkers of renal flare cycle could be used to detect the onset, severity, and responsiveness of kidney relapses, and to modify therapy accordingly. However, LN is a complex disease and individual biomarkers have so far not been sufficient to accurately describe disease activity. It has been postulated that biomarkers would be more informative if integrated into a pathogenic-based model of LN.

RESULTS

This work is a first attempt to integrate human LN biomarkers data into a model of kidney inflammation. Our approach is based on a system of differential equations that capture, in a simplified way, the complexity of interactions underlying disease activity. Using this model, we have been able to fit clinical urine biomarkers data from individual patients and estimate patient-specific parameters to reproduce disease dynamics, and to better understand disease mechanisms. Furthermore, our simulations suggest that the model can be used to evaluate therapeutic strategies for individual patients, or a group of patients that share similar data patterns.

CONCLUSIONS

We show that effective combination of clinical data and physiologically based mathematical modeling may provide a basis for more comprehensive modeling and improved clinical care for LN patients.

摘要

背景

尽管通过积极的免疫抑制疗法,狼疮性肾炎(LN)的预后已得到显著改善,但这些药物具有明显的副作用。为提高这些药物的疗效,可利用肾脏复发周期的生物标志物来检测肾脏复发的发作、严重程度和反应性,并据此调整治疗方案。然而,LN是一种复杂的疾病,迄今为止,单个生物标志物尚不足以准确描述疾病活动。据推测,如果将生物标志物整合到基于发病机制的LN模型中,其信息量会更大。

结果

这项工作首次尝试将人类LN生物标志物数据整合到肾脏炎症模型中。我们的方法基于一个微分方程系统,该系统以简化的方式捕捉疾病活动背后相互作用的复杂性。利用这个模型,我们能够拟合个体患者的临床尿液生物标志物数据,并估计患者特异性参数以重现疾病动态,从而更好地理解疾病机制。此外,我们的模拟表明,该模型可用于评估个体患者或具有相似数据模式的一组患者的治疗策略。

结论

我们表明,临床数据与基于生理学的数学建模的有效结合,可能为更全面的建模和改善LN患者的临床护理提供基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc8/2877652/fd7db7c38e75/1742-4682-7-14-9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc8/2877652/0f4dac684ab8/1742-4682-7-14-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc8/2877652/68ef76ac4342/1742-4682-7-14-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc8/2877652/f11c9313f728/1742-4682-7-14-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc8/2877652/6847556efd6a/1742-4682-7-14-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc8/2877652/b0e8318957e1/1742-4682-7-14-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc8/2877652/bcdd23ee9570/1742-4682-7-14-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc8/2877652/685da0bfac26/1742-4682-7-14-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc8/2877652/17982e287460/1742-4682-7-14-8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc8/2877652/fd7db7c38e75/1742-4682-7-14-9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc8/2877652/0f4dac684ab8/1742-4682-7-14-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc8/2877652/68ef76ac4342/1742-4682-7-14-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc8/2877652/f11c9313f728/1742-4682-7-14-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc8/2877652/6847556efd6a/1742-4682-7-14-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc8/2877652/b0e8318957e1/1742-4682-7-14-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc8/2877652/bcdd23ee9570/1742-4682-7-14-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc8/2877652/685da0bfac26/1742-4682-7-14-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc8/2877652/17982e287460/1742-4682-7-14-8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc8/2877652/fd7db7c38e75/1742-4682-7-14-9.jpg

相似文献

1
Mathematical framework for human SLE Nephritis: disease dynamics and urine biomarkers.人类系统性红斑狼疮性肾炎的数学框架:疾病动态与尿液生物标志物
Theor Biol Med Model. 2010 May 17;7:14. doi: 10.1186/1742-4682-7-14.
2
Urine biomarkers of chronic kidney damage and renal functional decline in childhood-onset systemic lupus erythematosus.儿童起病系统性红斑狼疮中慢性肾脏损伤和肾功能下降的尿液生物标志物。
Pediatr Nephrol. 2019 Jan;34(1):117-128. doi: 10.1007/s00467-018-4049-5. Epub 2018 Aug 29.
3
Immune-Related Urine Biomarkers for the Diagnosis of Lupus Nephritis.免疫相关尿液生物标志物在狼疮肾炎诊断中的应用。
Int J Mol Sci. 2021 Jul 1;22(13):7143. doi: 10.3390/ijms22137143.
4
Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.可溶性 TNF-R1、VEGF 和其他细胞因子作为系统性红斑狼疮和狼疮性肾炎疾病活动的标志物。
Lupus. 2019 May;28(6):713-721. doi: 10.1177/0961203319845487. Epub 2019 May 2.
5
Urine S100 proteins as potential biomarkers of lupus nephritis activity.尿液 S100 蛋白作为狼疮肾炎活动的潜在生物标志物。
Arthritis Res Ther. 2017 Oct 24;19(1):242. doi: 10.1186/s13075-017-1444-4.
6
Prediction Of Renal Flare In Adult Patients With Lupus Induced Nephritis.狼疮性肾炎成人患者的肾危象预测。
J Ayub Med Coll Abbottabad. 2021 Jan-Mar;33(1):9-13.
7
Discovery and Qualification of Candidate Urinary Biomarkers of Disease Activity in Lupus Nephritis.发现和鉴定狼疮肾炎疾病活动的候选尿液生物标志物。
J Proteome Res. 2019 Mar 1;18(3):1264-1277. doi: 10.1021/acs.jproteome.8b00874. Epub 2019 Jan 3.
8
Urinary biomarkers in childhood lupus nephritis.儿童狼疮性肾炎中的尿液生物标志物
Clin Immunol. 2017 Dec;185:21-31. doi: 10.1016/j.clim.2016.06.010. Epub 2016 Jun 29.
9
Urinary vitamin D-binding protein, a novel biomarker for lupus nephritis, predicts the development of proteinuric flare.尿维生素D结合蛋白是狼疮性肾炎的一种新型生物标志物,可预测蛋白尿复发的发生。
Lupus. 2018 Sep;27(10):1600-1615. doi: 10.1177/0961203318778774. Epub 2018 Jun 29.
10
Lupus nephritis biomarkers.狼疮性肾炎生物标志物
Clin Immunol. 2017 Dec;185:10-20. doi: 10.1016/j.clim.2016.08.001. Epub 2016 Aug 3.

引用本文的文献

1
Modelling the Impact of NETosis During the Initial Stage of Systemic Lupus Erythematosus.建模在系统性红斑狼疮初始阶段期间的 NETosis 影响。
Bull Math Biol. 2024 Apr 28;86(6):66. doi: 10.1007/s11538-024-01291-3.
2
Mathematical modeling in autoimmune diseases: from theory to clinical application.自身免疫性疾病的数学建模:从理论到临床应用。
Front Immunol. 2024 Mar 14;15:1371620. doi: 10.3389/fimmu.2024.1371620. eCollection 2024.
3
A biological and a mathematical model of SLE treated by mesenchymal stem cells covering all the stages of the disease.

本文引用的文献

1
Interferon-regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: a validation study.干扰素调节趋化因子作为系统性红斑狼疮疾病活动的生物标志物:一项验证研究。
Arthritis Rheum. 2009 Oct;60(10):3098-107. doi: 10.1002/art.24803.
2
Why can't we find a new treatment for SLE?为什么我们找不到系统性红斑狼疮的新治疗方法?
J Autoimmun. 2009 May-Jun;32(3-4):223-30. doi: 10.1016/j.jaut.2009.02.006. Epub 2009 Mar 28.
3
The chemokine network in systemic lupus erythematous nephritis.系统性红斑狼疮性肾炎中的趋化因子网络
一种治疗 SLE 的生物和数学模型,涉及疾病的所有阶段,由间充质干细胞治疗。
Theory Biosci. 2023 Jun;142(2):167-179. doi: 10.1007/s12064-023-00390-4. Epub 2023 Apr 18.
4
Urinary Neutrophil Gelatinase-Associated Lipocalin to Monitor Lupus Nephritis Disease Activity.尿中性粒细胞明胶酶相关脂质运载蛋白用于监测狼疮性肾炎的疾病活动度。
Biomark Insights. 2015 Sep 6;10:81-7. doi: 10.4137/BMI.S27625. eCollection 2015.
5
Human systems immunology: hypothesis-based modeling and unbiased data-driven approaches.人体系统免疫学:基于假设的建模和无偏数据驱动方法。
Semin Immunol. 2013 Oct 31;25(3):193-200. doi: 10.1016/j.smim.2012.11.003. Epub 2013 Jan 29.
6
Mucus distribution model in a lung with cystic fibrosis.囊性纤维化肺中的黏液分布模型。
Comput Math Methods Med. 2012;2012:970809. doi: 10.1155/2012/970809. Epub 2012 Oct 17.
Front Biosci. 2008 Jan 1;13:904-22. doi: 10.2741/2731.
4
Biomarker discovery in human SLE nephritis.人类系统性红斑狼疮肾炎的生物标志物发现
Bull NYU Hosp Jt Dis. 2007;65(3):187-93.
5
Dynamical properties of autoimmune disease models: tolerance, flare-up, dormancy.自身免疫性疾病模型的动力学特性:耐受性、发作、休眠。
J Theor Biol. 2007 Jun 21;246(4):646-59. doi: 10.1016/j.jtbi.2007.01.020. Epub 2007 Feb 3.
6
A reduced mathematical model of the acute inflammatory response: I. Derivation of model and analysis of anti-inflammation.急性炎症反应的简化数学模型:I. 模型推导与抗炎分析
J Theor Biol. 2006 Sep 7;242(1):220-36. doi: 10.1016/j.jtbi.2006.02.016. Epub 2006 Apr 3.
7
Plasma, urine, and renal expression of adiponectin in human systemic lupus erythematosus.人类系统性红斑狼疮中脂联素的血浆、尿液及肾脏表达情况。
Kidney Int. 2005 Oct;68(4):1825-33. doi: 10.1111/j.1523-1755.2005.00601.x.
8
Urine chemokines as biomarkers of human systemic lupus erythematosus activity.尿液趋化因子作为人类系统性红斑狼疮活动的生物标志物。
J Am Soc Nephrol. 2005 Feb;16(2):467-73. doi: 10.1681/ASN.2004080658. Epub 2004 Dec 15.
9
Exploring complement activation to develop biomarkers for systemic lupus erythematosus.探索补体激活以开发系统性红斑狼疮的生物标志物。
Arthritis Rheum. 2004 Nov;50(11):3404-7. doi: 10.1002/art.20602.
10
Severe lupus nephritis: importance of re-evaluating the histologic classification and the approach to patient care.重症狼疮性肾炎:重新评估组织学分类及患者护理方法的重要性。
J Nephrol. 2001 Jul-Aug;14(4):223-7.